Everyday exposures to EDCs in the environment may be linked to increasing rates of infertility, diabetes, immune deficiencies, and other serious conditions Highly Hazardous Pesticides pose ongoing threats, especially in the Global South A report from the world’s leading scientific and medical experts on hormone-related health conditions raises new concerns about the profound threats to...
On the 20th anniversary of the U.S. Food and Drug Administration’s approval of growth hormone (GH) treatment for idiopathic short stature (ISS), Adda Grimberg, MD, and Colin P. Hawkes, MD, PhD, both of the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, published a mini-review in The Journal...
Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &...
Childhood cancer patients and survivors are at increased risk for growth disturbances, for myriad reasons, and it is important to periodically monitor their growth, according to a paper recently published in The Journal of Clinical Endocrinology & Metabolism. Tomoko Yoshida, MD, PhD, and Angela Delaney, MD, both of St. Jude Children’s Research Hospital in Memphis,...
Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on...
The increase in free insulin-like growth factor (IGF)-I levels in prepubertal children with Prader-Willi Syndrome (PWS) treated with exogenous growth hormone (GH) could be caused by increased pregnancy-associated plasma protein A (PAPP-A, PAPP-A2) levels and a reduction in stanniocalcins (STC-1, STC-2), according to a study recently published in The Journal of Clinical Endocrinology & Metabolism....
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Medicare Coverage Significantly Expanded for the Eversense E3 CGM System On February 12, Ascensia Diabetes Care, announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of Local Coverage Determinations providing access to implantable CGM...
An Endocrine Society member since 1979, John William Honour, PhD, FRCPath, used his time in lockdown to write a voluminous tome on steroids. He talks to Endocrine News about his recent book, Steroids in the Laboratory and Clinical Practice, how it was impacted by the COVID-19 pandemic, and why it may just be the definitive...
An Endocrine Society member since 1979, John William Honour, PhD, FRCPath, used his time in lockdown to write a voluminous tome on steroids. He talks to Endocrine News about his recent book, Steroids in the Laboratory and Clinical Practice, how it was impacted by the COVID-19 pandemic, and why it may just be the definitive...
